期刊文献+

吲哚-3-甲醇对肺癌细胞放射敏感性的EGFR依赖性调节 被引量:3

EGFR-dependent Impact of Indol-3-Carbinol on Radiosensitivity of Lung Cancer Cells
下载PDF
导出
摘要 背景与目的吲哚-3-甲醇(indole-3-carbinol,I3C)是十字花科蔬菜中一种主要的有效植物化学物质,且具有防癌和抗癌作用。本研究旨在观察I3C是否影响表皮生长因子受体(epidermal growth factor receptor,EGFR)表达水平不同的肺癌细胞放射敏感性。方法采用MTT和克隆形成实验方法分别检测肺癌细胞的生长和存活率;siRNA转染方法降低细胞中EGFR蛋白表达水平;Western blot和RT-PCR法分别测定EGFR蛋白和mRNA的表达。结果采用无明显毒副作用的5mol/L剂量的I3C预处理明显降低了EGFR表达阳性的人肺腺癌H1975和人肺鳞癌H226细胞对γ-射线照射的放射敏感性,而I3C对EGFR表达阴性的人肺鳞癌NIH-H520细胞的放射敏感性则影响非常小。Western blot结果显示I3C可以增加H1975和H226细胞中EGFR蛋白的表达水平和Y845位点磷酸化水平。EGFR siRNA降低了NIH-H1975细胞中EGFR蛋白的表达,增加了细胞的放射敏感性,并有效地降低和抑制了I3C导致的细胞耐辐射效应。结论我们的研究结果首次证实I3C可以通过调节EGFR表达和磷酸化水平从而影响肺癌细胞的放射治疗敏感性,提示EGFR可能是I3C影响肺癌放射治疗敏感性的重要靶蛋白. Background and objective Indole-3-carbinol (I3C) is a naturally occurring phytochemical found in cruciferous vegetables. The aim of the present study is to investigate the influence of I3C on radiosensitivity in epidermal growth factor receptor (EGFR)-positive and EGFR-negative lung cancer cell lines. Methods Human lung adenocarcinoma NIH-H1975 cells and human lung squamous carcinoma NIH-H226 and NIH-H520 cells were routinely cultured in RPMI-1640. MTF assay and clonogenic assay were Used to detect cell growth and survival, respectively. Western blot and RT- PRC assay was employed to detect EGFR protein and mRNA expression. Results 5 μmol/L of I3C significantly reduced radiosensitivity of EGFR-positive NIH-H1975 and NIH-H226 cells, but failed to affect radiosensitivity of EGFR-negative NIH-HS20 cells. Furthermore, I3C caused an increased expression of total EGFR and pEGFR (Y845) protein in NIH-H1975 and NIH-H226 cell lines, but not in NIH-H520 cell line. A reduction of EGFR expression by EGFR-siRNA significantly inhib- ited I3C-caused radioresistance in NIH-H1975 cells. Conclusion Our data presented here for the first time demonstrate that I3C reduces radiosensitivity of lung cancer cells by mediating EGFR expression, indicating that EGFR may be an important tareet for I3C-mediated radioresistance in lung cancer.
出处 《中国肺癌杂志》 CAS 北大核心 2012年第7期391-398,共8页 Chinese Journal of Lung Cancer
基金 国家自然科学基金面上项目(No.81071906 No.81172127) 江苏省高等学校优秀科技创新团队(No.SZ132901)资助~~
关键词 吲哚-3-甲醇 肺肿瘤 放射敏感性 表皮生长因子受体 Indol-3-carbinol Lung neoplasms Radiosensitivity Epidermal growth factor receptor
  • 相关文献

参考文献15

  • 1Safe S, Papineni S, Chintharlapalli S. Cancer chemotherapy with indole-3- carbinol, bis (3'-indolyl) methane and synthetic analogs. Cancer Lett, 2008, 269(2): 326-338.
  • 2Das AK, Chen BP, Story MD, et al. Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma. Cancer Res, 2007,67(11): 5267-5274.
  • 3Mao Y, Wu J, Skog S, et al. Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and eDNA profiling. Oncol Rep, 2005,13(5): 837-846.
  • 4单利,韩志刚,刘莉,帕提古丽.阿尔西丁,王效刚,马玲,王强,张琰.晚期非小细胞肺癌ERCC1和BRCA1的表达及与顺铂耐药性的临床研究[J].肿瘤,2009,29(6):571-574. 被引量:26
  • 5尚晓滨,于振涛,唐鹏,张熙曾.DNA修复相关蛋白与肺癌顺铂耐药的关系[J].山东医药,2009,49(24):25-27. 被引量:8
  • 6Wang L, Wei], Qian X, et al. ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/ or docetaxel. BMC Cancer, 2008, 8: 97-100.
  • 7Harari PM, Huang SM. Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development. Semin Radiat Oncol,2002, 12(Suppl 2): 21-26.
  • 8谷海燕,项锋钢.新辅助化疗对非小细胞肺癌组织ERCC1和BRCA1表达影响[J].齐鲁医学杂志,2009,24(3):195-198. 被引量:4
  • 9Wachters FM, Wong LS, Timens WK, et al. ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy. Lung Cancer, 2005, 50(2): 211-219.
  • 10Tang Z, Du R, Jiang S, et al. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. Br J Cancer, 2008,99(6): 911-922.

二级参考文献82

  • 1陈东福,殷蔚伯,杨宗贻,张志贤,苗延浚,汪楣,张宏兴,谷铣之.非小细胞肺癌姑息术后放疗108例[J].中华放射肿瘤学杂志,1992,0(2):18-20. 被引量:11
  • 2许燕云,刘标,唐慰萍,吴艳霞.散发性乳腺癌中BRCA1和cyclinB1的表达[J].临床与实验病理学杂志,2004,20(3):273-276. 被引量:12
  • 3林莉,刘晓晴,宋三泰.DNA损伤修复与铂类耐药研究进展[J].中国肿瘤,2006,15(1):29-31. 被引量:29
  • 4俞洵宗,项锋钢.非小细胞肺癌新辅助化疗的研究进展[J].青岛大学医学院学报,2007,43(1):91-94. 被引量:6
  • 5Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging[ J ]. Chest, 1997,111 : 1718 - 1723.
  • 6Arriagada R, Bergman B, Dunant A, et al. Cisplatin based adjuvant chemotherapy in patients with completely resected non - small - cell lung cancer[ J ]. N Engl J Med,2004,350 : 351 - 360.
  • 7Rosell R, Cecere F, Santarpia M,et al. Predicting the outcome of chemotherapy for lung cancer[ J ]. Curr Opin Pharmacol, 2006,6 : 323 -331.
  • 8Zhou W, Liu G, Park S, et al. Gene smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer[ J]. Cancer Epidermal Biomarkers Prey, 2005,14 (2) :491 - 496.
  • 9Lord RV, Brabender J, Gandara D, et al. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non- small- cell lung cancer[ J]. Clin Cancer Res,2002 ,8 :2286 - 2291.
  • 10RoseU R, Lord RV, Taron M, et al. DNA repair and cisplatin resistance in non - small - cell lung cancer [ J ]. Lung Cancer , 2002, 38:217 - 227.

共引文献38

同被引文献34

  • 1Bradlow H L,Jon J Michnovicz,Nitin T Telang,et al. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice [J]. Carcinogenesis, 1991,12 (9) : 1571- 1574.
  • 2Chen I,Mcdougal A,Wang F,et al. Aryl hydrocarbon receptor- mediated antiestrogenic and antitumorigenic activity of diindo- lylmethane[J]. Carcinogen, 1998,19 : 1631-1639.
  • 3Tiwari R K,Guo L,Bradlow H L,ct al. Selective responsiveness of human breast cancer ceils to indole-3-carbinol,a chemopre- ventive agent[J]. J Natl Cancer Inst, 1994,86(2) : 126-131.
  • 4Yoshida M,Katashima S,Ando J,et al. Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initi- ated with N-ety-N'-nitrosoguanidine,with induction of cytochrome P450s in the liver and consequent nodulation of estrogen meta- bolism[J]. Carcinogen, 2004,25 : 2257-2264.
  • 5Bell,Peg Crowleg-Nowick,Bradlow,et al. Placebo-Controlled Trial of Indole-3-Carbinol in the Treatment of CIN[J]. Gynecologic Oncology, 2000,78 : 123-129.
  • 6Garikapaty V P,Ashok B T,Chen Y G,et al. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate caneer[J].Oncol Rep ,2005,13:89-93.
  • 7E Souli, Machluf M, Morgenstem A, et al. Indole-5-carbinol (I3C) exhibits inhibitory and preventive effects on prostate tumors in mice [ J ]. Food and Chemical Toxicology, 2008,46 : 863-870.
  • 8Shukla Y,Kalra N,Katiyar S,et al. Chemopreventive effect of indole-3-carbinol on induction of preneoplastic altered hepatic foci[J]. Nutr Cancer,2004,50:214-220.
  • 9Yoshida M,Katashima S,Ando J,et al. Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initi- ated with N-ethyl-N'-nitro-N-nitrosogua-nidine,with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism[J]. Careino-genesis,2004,25:2257-2264.
  • 10Donald S,Verschoyle R D,Greaves P,et al. Dietary agent in- dole-3-carbinol protects female rats against the hepatotoxicity of the antitumor drug ET-743 (trabectidin) without compro- mising efficacy in a rat mammary carcinoma[J]. Int J Cancer, 2004,111 : 961-967.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部